Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19

NCT04552483 is registered in ClinicalTrials.gov with Universidade Federal do Rio de Janeiro as lead sponsor.

NCT NCT04552483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04552483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19
Lead sponsor
Universidade Federal do Rio de Janeiro
Phase
Phase 2
Overall status
Completed
Start date
June 8, 2020
Completion date
September 5, 2020
Enrollment
392 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid19